Insider Selling: Doximity, Inc. (NASDAQ:DOCS) Director Sells $70,450.00 in Stock

Doximity, Inc. (NASDAQ:DOCSGet Free Report) Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $28.18, for a total value of $70,450.00. Following the completion of the sale, the director now owns 10,258 shares of the company’s stock, valued at approximately $289,070.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Kira Scherer Wampler also recently made the following trade(s):

  • On Monday, July 1st, Kira Scherer Wampler sold 2,500 shares of Doximity stock. The shares were sold at an average price of $28.00, for a total transaction of $70,000.00.
  • On Friday, May 17th, Kira Scherer Wampler sold 2,500 shares of Doximity stock. The shares were sold at an average price of $27.22, for a total transaction of $68,050.00.

Doximity Stock Down 1.5 %

Shares of NASDAQ:DOCS opened at $26.99 on Monday. The firm has a 50-day simple moving average of $28.03 and a 200 day simple moving average of $27.41. The company has a market cap of $5.00 billion, a PE ratio of 37.49, a P/E/G ratio of 5.12 and a beta of 1.22. Doximity, Inc. has a fifty-two week low of $19.71 and a fifty-two week high of $34.56.

Doximity (NASDAQ:DOCSGet Free Report) last issued its quarterly earnings data on Thursday, May 16th. The company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. Doximity had a return on equity of 17.44% and a net margin of 31.04%. The firm had revenue of $118.06 million during the quarter, compared to the consensus estimate of $116.46 million. As a group, research analysts forecast that Doximity, Inc. will post 0.74 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on DOCS shares. Evercore ISI boosted their price objective on shares of Doximity from $28.00 to $29.00 and gave the stock an “in-line” rating in a report on Friday, May 17th. Needham & Company LLC reissued a “hold” rating on shares of Doximity in a report on Friday, May 17th. Wells Fargo & Company lowered Doximity from an “equal weight” rating to an “underweight” rating and lowered their price objective for the company from $27.00 to $19.00 in a research note on Thursday, July 18th. William Blair reaffirmed an “outperform” rating on shares of Doximity in a research report on Friday, May 17th. Finally, JPMorgan Chase & Co. raised shares of Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price target for the company in a research report on Thursday, April 25th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $28.00.

View Our Latest Stock Report on DOCS

Institutional Trading of Doximity

A number of large investors have recently modified their holdings of DOCS. Norges Bank bought a new position in Doximity in the 4th quarter worth about $35,995,000. Blair William & Co. IL grew its stake in shares of Doximity by 31.7% in the first quarter. Blair William & Co. IL now owns 90,600 shares of the company’s stock worth $2,438,000 after purchasing an additional 21,787 shares in the last quarter. Edmond DE Rothschild Holding S.A. increased its holdings in shares of Doximity by 15.1% during the fourth quarter. Edmond DE Rothschild Holding S.A. now owns 2,302,240 shares of the company’s stock valued at $64,555,000 after purchasing an additional 301,290 shares during the period. Pinebridge Investments L.P. bought a new stake in shares of Doximity during the fourth quarter valued at about $2,845,000. Finally, Acadian Asset Management LLC lifted its holdings in Doximity by 128.7% in the first quarter. Acadian Asset Management LLC now owns 96,442 shares of the company’s stock worth $2,590,000 after purchasing an additional 54,281 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.

About Doximity

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Read More

Insider Buying and Selling by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.